Diabetes

News

FDA finds no link between GLP-1 drugs and suicide

The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide, saying it can find no evid

News

JPM: Amazon, Omada launch digital health benefits alliance

Amazon has launched a health monitoring programme in partnership with Omada Health that aims to identify people who may be eligible for enrolment into the latter’s disease

News

Lilly launches telehealth option for obesity and other drugs

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that could shake up

R&D

The race for obesity drug assets heats up

The existing treatments for weight loss have drawn interest from across the industry, as their efficacy and sales potential become evident.

News

Medtronic drops $738m takeover of wearable insulin pump firm

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple b

News

Trial finds Lilly’s Olumiant could treat type 1 diabetes

Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, pote

FDA finds no link between GLP-1 drugs and suicide

JPM: Amazon, Omada launch digital health benefits alliance

Lilly launches telehealth option for obesity and other drugs

The race for obesity drug assets heats up

Medtronic drops $738m takeover of wearable insulin pump firm

Trial finds Lilly’s Olumiant could treat type 1 diabetes

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Diabetes

Editor's Picks